Viewing Study NCT06398405


Ignite Creation Date: 2025-12-25 @ 3:21 AM
Ignite Modification Date: 2026-03-30 @ 5:22 AM
Study NCT ID: NCT06398405
Status: RECRUITING
Last Update Posted: 2024-05-03
First Post: 2024-04-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Clinical Study of Epigallocatechin-3-gallate in Patients With Esophageal Squamous Cancer
Sponsor: Shandong Cancer Hospital and Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module